The report covers the present ground scenario and the future growth prospects of Africa Pharmaceuticals Market. Furthermore, it includes statistics of Branded and Generic Drugs along with the details of ongoing projects in the pharma sector in Africa.
REIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging Marketmohamed saad
Cancer is one of the most feared diseases in the world and, while the ‘magic bullet’ cure has so far failed to materialize, there are new breeds of therapeutics, such as epidermal growth factor receptor (EGFR) inhibitors and vascular endothelial growth factor (VEGF) inhibitors, that are making a real impact on patient survival. However, improvements in survival come at a cost, and hefty increases in oncology drug prices are making life difficult for those agencies whose job it is to make reimbursement decisions.
The promises of unregulated pricing and the largest oncology market in the world have made the US the most popular entry point for new oncology drugs.
However, what i am suggesting here, is recommended penetration strategy for emerging market ( Malaysia)
Let me know your thoughts
Thanks you
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Aiswariya Chidambaram
This presentation made at the Pharma Insights Briefing session of CPhI Worldwide 2014, Paris, provides information on the market opportunities of
the fastest growing pharmaceutical markets in Africa: Ghana and Nigeria.
• Market sizing and Growth Trends
• Key Merger, Acquisition and Partnership Assessment
• Market Drivers and Challenges
• Pharmaceutical Procurement, Supply, Distribution and Retail
• SWOT and PESTLE Analysis
• Competitive Landscape Analysis
• Therapeutic Area Growth Analysis
• Strategic Recommendations
East African Pharmaceutical Sector: Opportunities and ChallengesPharmaAfrica
Presentation by Nazeem Mohamed, Federation of East African Pharmaceutical Manufacturers made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.
REIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging Marketmohamed saad
Cancer is one of the most feared diseases in the world and, while the ‘magic bullet’ cure has so far failed to materialize, there are new breeds of therapeutics, such as epidermal growth factor receptor (EGFR) inhibitors and vascular endothelial growth factor (VEGF) inhibitors, that are making a real impact on patient survival. However, improvements in survival come at a cost, and hefty increases in oncology drug prices are making life difficult for those agencies whose job it is to make reimbursement decisions.
The promises of unregulated pricing and the largest oncology market in the world have made the US the most popular entry point for new oncology drugs.
However, what i am suggesting here, is recommended penetration strategy for emerging market ( Malaysia)
Let me know your thoughts
Thanks you
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Aiswariya Chidambaram
This presentation made at the Pharma Insights Briefing session of CPhI Worldwide 2014, Paris, provides information on the market opportunities of
the fastest growing pharmaceutical markets in Africa: Ghana and Nigeria.
• Market sizing and Growth Trends
• Key Merger, Acquisition and Partnership Assessment
• Market Drivers and Challenges
• Pharmaceutical Procurement, Supply, Distribution and Retail
• SWOT and PESTLE Analysis
• Competitive Landscape Analysis
• Therapeutic Area Growth Analysis
• Strategic Recommendations
East African Pharmaceutical Sector: Opportunities and ChallengesPharmaAfrica
Presentation by Nazeem Mohamed, Federation of East African Pharmaceutical Manufacturers made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.
The presentation discuss the size of the generic market in the Middle East and defining Jordan as a location suitable and attractive to put manufacturing plants.
The statistics also include health spending by country
Key success factors to win in MENA pharmaceutical market, Market access planning, creating value, major challenges and changes in Pharmaceutical culture in MENA
Presentation by Adil Zanfari, President, Genpharma, Morocco made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.
Presentation by NEPAD Agency on the African Medicines Regulatory Harmonisation made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.
Target Market - A continent rich in prospects and enthusiasm, Africa could ha...PharmaAfrica
European Biopharmaceutical Review talks to PharmaAfrica about the vibrant and wide-ranging opportunities on offer for pharma companies looking to expand into new directions. July 2015 edition
The recipe for excellence in pharmaceutical practice spotlight on menaMoustafa Magdy
This presentations provides an overview about the pharmaceutical business in Middle East Africa Region as well as practical guidance about business operation for excellence
Mena pharmaceuticals steps for successful model tphWesam Nehad
This is my presentation in Turkish and MENA pharmaceutical summit 3rd Nov.2015 in Istanbul
I tried to provide audience with practical steps to enter MENA pharmaceutical markets starting from market selection and prioritize them based on market size, growth, investment attractiveness, regulatory and setup challenges..etc. then the most common challenges and critical success factors to overcome most of those challenges ex. Entry models discussions, RA challenges, and reimbursement and market access challenges.
I end that with one interesting slide for XYZ product market access plan which took some discussions: when to start till the launch date, definitely market access shouldn't stop at the launch.. it is a continuous process
Hope you enjoy it and definitely I'm willing to share more information if required
Analysis On Global Drugs for Prostate Cancer Market Research, Demands & Produ...Pallavi Pawar
The global Drugs for Prostate Cancer market the target of analysis of the research report recently added to the expansive database in QYResearchReports.com. The extremely descriptive and insightful document chalks out a thorough and all-inclusive analytical perspective of the global Drugs for Prostate Cancer market, covering all key categories and their segments, along with the factors that have the potential of being influential on the market in the near future. The report thus presents a 360-degree analysis of the current state of the global Drugs for Prostate Cancer market to the reader.
The market has been excavated from a ground-up fashion, where rudimentary data and key, industry-specific definitions of the global Drugs for Prostate Cancer market’s elements are described in the overview. The report moves ahead to the complete analysis of global Drugs for Prostate Cancer market, sticking to aspects such as classifications, industry chain structure, applications, policies, industry overview, and recent developments.
The presentation discuss the size of the generic market in the Middle East and defining Jordan as a location suitable and attractive to put manufacturing plants.
The statistics also include health spending by country
Key success factors to win in MENA pharmaceutical market, Market access planning, creating value, major challenges and changes in Pharmaceutical culture in MENA
Presentation by Adil Zanfari, President, Genpharma, Morocco made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.
Presentation by NEPAD Agency on the African Medicines Regulatory Harmonisation made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.
Target Market - A continent rich in prospects and enthusiasm, Africa could ha...PharmaAfrica
European Biopharmaceutical Review talks to PharmaAfrica about the vibrant and wide-ranging opportunities on offer for pharma companies looking to expand into new directions. July 2015 edition
The recipe for excellence in pharmaceutical practice spotlight on menaMoustafa Magdy
This presentations provides an overview about the pharmaceutical business in Middle East Africa Region as well as practical guidance about business operation for excellence
Mena pharmaceuticals steps for successful model tphWesam Nehad
This is my presentation in Turkish and MENA pharmaceutical summit 3rd Nov.2015 in Istanbul
I tried to provide audience with practical steps to enter MENA pharmaceutical markets starting from market selection and prioritize them based on market size, growth, investment attractiveness, regulatory and setup challenges..etc. then the most common challenges and critical success factors to overcome most of those challenges ex. Entry models discussions, RA challenges, and reimbursement and market access challenges.
I end that with one interesting slide for XYZ product market access plan which took some discussions: when to start till the launch date, definitely market access shouldn't stop at the launch.. it is a continuous process
Hope you enjoy it and definitely I'm willing to share more information if required
Analysis On Global Drugs for Prostate Cancer Market Research, Demands & Produ...Pallavi Pawar
The global Drugs for Prostate Cancer market the target of analysis of the research report recently added to the expansive database in QYResearchReports.com. The extremely descriptive and insightful document chalks out a thorough and all-inclusive analytical perspective of the global Drugs for Prostate Cancer market, covering all key categories and their segments, along with the factors that have the potential of being influential on the market in the near future. The report thus presents a 360-degree analysis of the current state of the global Drugs for Prostate Cancer market to the reader.
The market has been excavated from a ground-up fashion, where rudimentary data and key, industry-specific definitions of the global Drugs for Prostate Cancer market’s elements are described in the overview. The report moves ahead to the complete analysis of global Drugs for Prostate Cancer market, sticking to aspects such as classifications, industry chain structure, applications, policies, industry overview, and recent developments.
Anal Cancer Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The Anal Cancer Market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Anal Cancer Market.
Intracranial Abscess Treatment Market: Covid-19 Impact Analysis, Supply Demand Scenario and Growth Prospects Survey till 2030 investigated in the latest research
Liquid Biopsy Market PPT 2023: Size, Growth, Demand and Forecast till 2028IMARC Group
The global liquid biopsy market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.
More Info:- https://www.imarcgroup.com/liquid-biopsy-market
Pharmacogenomics market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028
Similar to Africa pharmaceutical market, industry analysis, forecast 2024 (20)
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
3. MARGIE'STRAVEL
3
M
Summary
• Half of Africans do not have access to essential drugs. With the
provision of the right drugs to treat respiratory infections, diarrheal
diseases and malaria, around 10 million lives would have been
saved in 2015.
• Africa pharmaceuticals market size is set to reach USD 160.7
billion by 2024, at a CAGR of 20.4% over the forecast years.
• Africa Pharmaceuticals Market for 2016-2024 and statistics of
Branded and Generic Drugs along with the details of ongoing
projects in pharma sector in Africa.
• The 10 largest pharmacy retail chains in Nigeria, Kenya and
Ghana manage 186 outlets for a population of almost a quarter of
a billion people.
6. MARGIE'STRAVEL
6
M
Key Questions
• What is the total market size by 2024 and what would be the expected growth rate
of Africa Pharmaceutical Industry?
• What is the revenue of Africa Pharmaceutical Market in 2015-16 and what would
be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?
7. MARGIE'STRAVEL
7
M
Related Reports
• Middle East and Africa 3D printing in healthcare Market (2018-2023)
• Middle East and Africa Smart Hospital Market (2018-2023)
• Global Radiopharmaceutical Market Research Report - Forecast to 2023
• Zoetis: Performance, Capabilities, Goals and Strategies in the Global
Pharmaceutical Market
8. MARGIE'STRAVEL
8
M
About Us
Aarkstore forms global market research reports
from various industry verticals serving businesses
worldwide. As market research report resellers,
we partner with already established publishers for
syndicated data and customized reports.
Consequently, market research data by us is up-
to-date and reliable for Industry analysis and
future market forecasts.
